Casein kinase 1 regulates Sprouty2 in FGF-ERK signaling
D G R Yim1, S Ghosh2, G R Guy3
11] Program in Cancer and Stem Cell Biology, Duke-NUS Graduate Medical School, Singapore, Singapore [2] Signal Transduction Laboratory, Institute for Molecular and Cellular Biology, Biopolis, Singapore [3] Genome Institute of Singapore, Biopolis, Singapore.
Abstract:
Sprouty2 (SPRY2) is a potent negative regulator of receptor tyrosine kinase signaling, and is implicated as a tumor suppressor. SPRY2 inhibits FGF-RAS-ERK signaling by binding to growth factor receptor bound protein 2 (GRB2) during fibroblast growth factor receptor (FGFR) activation, disrupting the GRB2-SOS (son of sevenless) complex that transduces signals from FGFR to RAS. SPRY2 binding to GRB2 is modulated by phosphorylation but the key regulatory kinase(s) are not known. Prior studies identified the frequent presence of CK1 phosphorylation motifs on SPRY2. We therefore tested if CK1 has a role in SPRY2 phosphorylation and function. Loss of CK1 binding and inhibition of CK1 activity by two structurally distinct small molecules abrogated SPRY2 inhibition of FGF-ERK signaling, leading to decreased SPRY2 interaction with GRB2. Moreover, CK1 activity and binding are necessary for SPRY2 inhibition of FGF-stimulated neurite outgrowth in PC12 cells. Consistent with its proposed role as an inhibitor of FGF signaling, we find that CSNK1E transcript abundance negatively correlates with FGF1/FGF7 message in human gastric cancer samples. Modulation of CK1 activity may be therapeutically useful in the treatment of FGF/SPRY2-related diseases.
Insights
Casein kinase 1 (CK1) phosphorylates Sprouty2 (SPRY2), a tumor suppressor. CK1 activity is essential for SPRY2
Area of Science:
- Molecular Biology
- Cell Signaling
- Oncology
Background:
- Sprouty2 (SPRY2) acts as a tumor suppressor by negatively regulating receptor tyrosine kinase signaling pathways.
- SPRY2 inhibits fibroblast growth factor receptor (FGFR) signaling by interfering with the GRB2-SOS complex, which is crucial for RAS-ERK pathway activation.
- The phosphorylation of SPRY2 by kinases modulates its interaction with GRB2, but the specific kinases involved remain unidentified.
Purpose of the Study:
- To investigate the role of Casein Kinase 1 (CK1) in the phosphorylation and function of Sprouty2 (SPRY2).
- To determine if CK1 activity is required for SPRY2's inhibitory effects on FGF-RAS-ERK signaling and FGF-stimulated cellular processes.
Main Methods:
- Assessed the effect of CK1 inhibition and disruption of CK1-SPRY2 binding on SPRY2's ability to inhibit FGF-ERK signaling.
- Examined the impact of CK1 activity on SPRY2's interaction with GRB2.
- Evaluated the necessity of CK1 activity for SPRY2's inhibition of FGF-stimulated neurite outgrowth in PC12 cells.
- Correlated CSNK1E transcript levels with FGF1/FGF7 expression in human gastric cancer samples.
Main Results:
- Inhibition of CK1 activity or disruption of CK1 binding to SPRY2 abrogated SPRY2's inhibitory effect on FGF-ERK signaling.
- CK1 activity was found to be necessary for SPRY2's interaction with GRB2.
- CK1 activity and binding are critical for SPRY2 to inhibit FGF-stimulated neurite outgrowth in PC12 cells.
- CSNK1E transcript abundance showed a negative correlation with FGF1/FGF7 message in gastric cancer, supporting SPRY2's inhibitory role.
Conclusions:
- CK1 is a key kinase that phosphorylates SPRY2, regulating its function as a negative modulator of FGF signaling.
- CK1 activity is essential for SPRY2's tumor suppressor function by maintaining its inhibitory interaction with GRB2.
- Targeting CK1 activity may offer a therapeutic strategy for FGF/SPRY2-related diseases, including certain cancers.
Related Concept Videos
TGF - β Signaling Pathway
PI3K/mTOR/AKT Signaling Pathway
MAPK Signaling Cascades
Cell Signaling in Plants
Hedgehog Signaling Pathway
Notch Signaling Pathway


